A large consortium of European health-related stakeholders, including industry players, academia, healthcare professionals and patients, share their satisfaction on the draft adequacy decision on the UK data protection regime issued by the European Commission on 19th February 2021. Protecting the benefits of the free flow… read more
According to the MHRA Guidance, up until 31 December 2021, medicines can be supplied from Great Britain (GB) to Northern Ireland (NI) with a “pragmatic approach” to applying EU rules on importation and unique identifier requirements. Outside of these two areas, medicines supplied to NI have… read more
EUCOPE, together with other European pharmaceutical trade associations, wrote a letter to the presidents of the Commission, Council and Parliament, as well as Trade Commissioner Phil Hogan and the EU’s chief negotiator Michel Barnier, voicing our shared concern about the lack of progress within the… read more
EUCOPE, together with 16 associations representing patients, healthcare professionals and the pharmaceutical and devices industry have joined efforts in supporting the event “Brexit: the European Parliament’s role in prioritising patients, public health and health security across Europe”, to be held on September the 12th in… read more
The European Commission published on the 12 June its 5th state-of-play communication on the preparation of contingency measures for the withdrawal of the United Kingdom from the European Union (Brexit). In its 10-page document, the Commission reiterates its recommendation for a high level of preparedness… read more
Keep up-to-date on all of the most pertinent policy files and regulatory news around the world of European health technologies with our monthly newsletter – the Innovation Eye-View